Skip to main content

Table 3 Non-Poliovirus Inhibitors

From: Recent advances on the role of host factors during non-poliovirus enteroviral infections

Drug compound

Virus

Mode of action

Reference

Andrographolide

EV-D68

Suppresses maturation of the virus within the acidic endosomes.

[182]

DTriP

EV-A71

Blocks viral replication by targeting the RNA dependent RNA polymerase.

[195]

Ribavirin

EV-A71

General reduction of the viral yield

[179]

Quercetin

EV-A71

Inhibits virus attachment, adsorption and the viral 3C protease

[180]

Rupintrivir

EV-A71, CV-A16, HRV

Binds and inhibits viral 3C protease activity

[196,197,198]

Fluoxetine

CV-B3

Reduces synthesis of viral RNA and protein

[199]

Dibucaine

CV-B3, EV-D68,

RNA replication stage; may be targeting CV-B3 viral 2C protease

[184]

Formoterol

CV-B3, EV-D68, EV-A71, RV-A2, RV-B14

Likely inhibit RV-14 by reducing ICAM-1 levels or acidic endosomes.

[184, 200]

Pirlindole

EV-D68 and CV-B3

RNA replication stage; may be targeting CV-B3 viral 2C protease

 

Budesonide

RV-14

 

[200]

Zuclopenthixol

EV-D68 and CV-B3

RNA replication stage; may be targeting CV-B3 viral 2C protease

[184]

Apigenin

EV-A71

Targeting viral IRES thereby inhibiting viral translation process

[191,192,193]